Price
No data yet.
Social Signal Score
Analyst Ratings
24 analystsRevenue
$615.49M-31.72%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Sharon Price John
- Sector
- Consumer Cyclical
- Industry
- Apparel - Retail
- Employees
- 15,400
- Beta
- 0.83
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.75
Financials
Revenue
$615.49M-31.7%Net Income
$104.96M+31.9%EBITDA
$150.70M+1.5%Free Cash Flow
$190.04M+1904.0%EPS (diluted)
$2.96+85.0%Shares Outstanding (diluted)
35.44M-29.1%Operating Expenses
$276.13MCash & Debt
$653.57MReturn of Capital
$9.13MRevenue by Segment (annual)
$2.90BDividend per Share
$0.25Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.90B | $91.80M | $2.59 |
| 2024 | $2.84B | $185.51M | $5.12 |
| 2023 | $2.95B | $232.50M | $6.24 |
| 2022 | $3.21B | $250.04M | $6.34 |
| 2021 | $3.49B | $339.75M | $7.83 |
| 2020 | $3.02B | $109.72M | $2.51 |
| 2019 | $3.52B | $263.80M | $5.89 |
| 2018 | $3.46B | $282.07M | $6.11 |
| 2017 | $3.40B | $302.76M | $6.31 |
| 2016 | $3.20B | $258.11M | $5.13 |
| 2015 | $3.01B | $237.82M | $4.55 |
| 2014 | $2.89B | $194.67M | $3.65 |
| 2013 | $2.64B | $160.41M | $2.78 |
| 2012 | $2.38B | $161.15M | $2.73 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CRI's reported EPS growth of -0.4% a year over 13 years.
- EPS in 5 years
- $2.54
- Implied price
- $33.00
- Return from $31.59
- 0.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $16.41 — -48.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 9 | 11 | 13 | 15 | 17 |
|---|---|---|---|---|---|
| -10.4% | -15.7% | -12.2% | -9.3% | -6.6% | -4.2% |
| -5.4% | -11.0% | -7.3% | -4.2% | -1.4% | 1.1% |
| -0.4% | -6.3% | -2.4% | 0.9% | 3.8% | 6.4% |
| 4.6% | -1.6% | 2.5% | 5.9% | 9.0% | 11.8% |
| 9.6% | 3.1% | 7.4% | 11.0% | 14.2% | 17.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70-60.00%Social Signal Score
Mentions (14)
- Newszacks.com·5d ago·Positive
Carter's Stock Trading at a Discount: What's the Next Best Move? CRI trades at a discount as improving retail, wholesale and digital trends support growth despite consumer, promotional and tariff pressures.
View source ↗ - Newszacks.com·13d ago·Neutral
Implied Volatility Surging for Carter's Stock Options Investors need to pay close attention to CRI stock based on the movements in the options market lately.
View source ↗ - Newsseekingalpha.com·19d ago·Neutral
Carter's: Attractive As Tariff Headwind Inflects Carter's (CRI) remains a buy after a recent sell-off, with shares trading at attractive 9x earnings and positive same-store sales momentum. A $132 million tariff refund and improved working capital have fortified CRI's balance sheet, enabling debt reduction and securing its 3.3% dividend yield. New CEO Sharon Price John is positioned to drive growth, with Gen Z traction and easing tariff headwinds supporting a margin inflection in H2.
View source ↗ - Newszacks.com·24d ago·Neutral
Carter's Growth Supported by Brands, Digital Efforts & Cost Savings CRI's growth strategy centers on brand innovation, digital expansion and productivity initiatives to strengthen sales and offset tariff pressures.
View source ↗ - Newszacks.com·39d ago·Positive
Carter's Growth Story Gains Strength: Is More Upside Ahead? CRI's recovery gains strength as sales growth, retail momentum and digital investments support improving execution and a stronger growth trajectory.
View source ↗ - Newszacks.com·41d ago·Neutral
Carter's (CRI) Loses 11.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Carter's (CRI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
View source ↗ - Newszacks.com·43d ago·Positive
New Strong Buy Stocks for August 24th FHI, NVT, NESR, CRD.B and CRI have been added to the Zacks Rank #1 (Strong Buy) List on August 24th, 2026.
View source ↗ - Newszacks.com·45d ago·Neutral
Carter's (CRI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now After losing some value lately, a hammer chart pattern has been formed for Carter's (CRI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
View source ↗ - Newsbusinesswire.com·46d ago·Negative
Carter's, Inc. Announces Quarterly Dividend ATLANTA--(BUSINESS WIRE)--The Board of Directors of Carter's, Inc. (NYSE:CRI) today declared a quarterly dividend of $0.25 per share, payable on September 25, 2026, to shareholders of record at the close of business on September 1, 2026. Future declarations of quarterly dividends and the establishment of future record and payment dates will be at the discretion of the Company's Board of Directors based on a number of factors, including business conditi…
View source ↗ - Newszacks.com·47d ago·Positive
Carter's Stock Surges 52% in a Year: Is It Time to Buy or Wait? CRI's rally reflects stronger sales momentum and a consumer-led strategy, while digital investments and cost savings support growth.
View source ↗ - Newszacks.com·54d ago·Neutral
Carter's (CRI) Is Up 3.60% in One Week: What You Should Know Does Carter's (CRI) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·56d ago·Positive
Carter's Gains 19.4% in 3 Months as Growth Momentum Supports Upside Case CRI Q2 beat estimates as retail, e-commerce and international growth gained momentum, while tariffs remain a key risk to margins.
View source ↗ - Newszacks.com·56d ago·Positive
Is CRI a Buy After Growth Gains Despite Retail Risks Ahead? Carter's Q2 momentum and raised outlook strengthen its recovery case, but tariff uncertainty, pricing pressure and consumer risks remain key concerns.
View source ↗ - Newszacks.com·56d ago·Positive
CRI Earnings Beat Raises Questions on Tariff Recovery and Growth Trend Carter's Q2 beat estimates on retail, wholesale and productivity gains, but tariff recoveries and softer demand cloud the recovery outlook.
View source ↗
Earnings
Mon, Oct 26(in 3 weeks)
Consensus estimate $0.89 per share
Typical surprise +24.5% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Jul 31$0.26 vs $0.06beat
- Wed, May 6$0.39 vs $0.13beat
- Fri, Feb 27$1.90 vs $1.70beat
- Mon, Oct 27$0.74 vs $0.78miss
- Fri, Jul 25$0.17 vs $0.43miss
- Fri, Apr 25$0.66 vs $0.53beat
Estimates and results for CRI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CRI officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Nov 11, 2024 (26d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 8, 2024 (35d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (14d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (12d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (13d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (8d later)Sell$50,001 - $100,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (12d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (20d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (19d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (11d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (12d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (19d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 12, 2023 (20d later)Sell$50,001 - $100,000
- Ro Khannahouse · CA17 · disclosed May 8, 2023 (28d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Apr 7, 2023 (8d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 7, 2022 (36d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 7, 2022 (14d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 7, 2022 (15d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 7, 2022 (31d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 7, 2022 (31d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.